Biden wants to cover weight loss meds. RFK Jr. would rather we just eat better.
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr. may not be such a fan.
Medications, Including Injectable Weight-Loss Drugs, Make Up One-Third of VA's Projected 2025 Budget Shortfall
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as Ozempic and Wegovy, which the Biden administration announced Tuesday should be covered for Medicare patients.
Medicare moves to expand coverage for weight-loss drugs Wegovy, Zepbound
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and Zepbound.
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morni
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal.
Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans
Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans
Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans.
What to know about the Biden administration proposal to expand access to weight loss drugs
The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would allow millions of obese Americans covered by Medicaid and Medicare to be eligible for the drugs.
Biden proposes huge expansion of weight loss drug access
Outgoing US President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs -- but Donald Trump's incoming health chief looked set to shoot down the
Detroit News5h
Dr. Roach: In two cases, Zepbound provides great benefit to overall health
Dear Dr. Roach: My husband and I have started taking Zepbound for various medical reasons. The medication has significantly ...
HealthDay on MSN15h
Zepbound Slashes Diabetes Risk in Obese Users
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...
The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...
Weight-loss drug Zepbound might help manage heart failure
Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...
Eli Lilly’s Stock Poised for Growth Amid Potential CMS Coverage for Zepbound
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...
BioSpace20h
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...
Sun Journal10h
In two cases, Zepbound provides great benefit to overall health
Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: My husband and I have started taking Zepbound for various medical reasons. The medication has significantly ...
Investor's Business Daily on MSN1d
Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...